Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 242 entries
View as:

A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00243971 Org: User:
Start: 11/30/04 End: 10/31/05 Due: 10/31/06

Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older

Phase: N/A Priority: Normal
NCT ID: NCT01236001 Org: User:
Start: 09/30/10 End: 03/31/12 Due: 03/31/13

Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT01536015 Org: User:
Start: 01/31/12 End: 10/31/13 Due: 10/31/14

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

Phase: N/A Priority: Normal
NCT ID: NCT00175864 Org: User:
Start: 02/28/06 End: - Due: -

Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT01646268 Org: User:
Start: 07/31/12 End: 05/31/14 Due: 05/31/15

A Trial to Assess the Efficacy and Safety of SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00238524 Org: User:
Start: 12/31/03 End: 01/31/05 Due: 01/31/06

A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00105040 Org: User:
Start: 09/30/04 End: 03/31/07 Due: 03/31/08

Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00152516 Org: User:
Start: 10/31/04 End: 06/30/08 Due: 06/30/09

Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease

Phase: N/A Priority: Normal
NCT ID: NCT00660881 Org: User:
Start: 05/31/08 End: 12/31/11 Due: 12/31/12

Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00292227 Org: User:
Start: 01/31/06 End: 10/31/06 Due: 10/31/07

Mucosal Healing Study in Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT00297648 Org: User:
Start: 02/28/06 End: 12/31/09 Due: 12/31/10

A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00350103 Org: User:
Start: 06/30/06 End: 06/29/07 Due: 06/29/08

Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00544388 Org: User:
Start: 04/30/04 End: 07/31/04 Due: 07/31/05

Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation

Phase: N/A Priority: Normal
NCT ID: NCT01386944 Org: User:
Start: 07/31/11 End: 08/31/13 Due: 08/31/14

Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia

Phase: N/A Priority: Normal
NCT ID: NCT00175955 Org: User:
Start: 05/31/05 End: 12/31/05 Due: 12/31/06

Conversion to Monotherapy Study With Keppra XR for Partial Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00419094 Org: User:
Start: 08/31/07 End: 09/30/09 Due: 09/30/10

Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.

Phase: N/A Priority: Normal
NCT ID: NCT00245713 Org: User:
Start: 03/31/03 End: 11/30/04 Due: 11/30/05

A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00220337 Org: User:
Start: 12/21/04 End: 10/31/07 Due: 10/31/08

A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00139880 Org: User:
Start: 06/30/05 End: 08/31/05 Due: 08/31/06

Study of Epratuzumab in Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT00111306 Org: User:
Start: 06/30/05 End: 03/31/07 Due: 03/31/08

Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children

Phase: N/A Priority: Normal
NCT ID: NCT00520754 Org: User:
Start: 12/31/01 End: 03/31/03 Due: 03/31/04

A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)

Phase: N/A Priority: Normal
NCT ID: NCT00152490 Org: User:
Start: 12/31/03 End: 05/31/05 Due: 05/31/06

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Phase: N/A Priority: Normal
NCT ID: NCT01375374 Org: User:
Start: 07/31/11 End: 03/31/13 Due: 03/31/14

Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00535392 Org: User:
Start: 09/30/07 End: 02/28/10 Due: 02/28/11

Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam

Phase: N/A Priority: Normal
NCT ID: NCT00319605 Org: User:
Start: 04/30/06 End: 07/31/06 Due: 07/31/07